相关实验视频

Updated: Sep 16, 2025

Quantification of Hypopigmentation Activity In Vitro

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

对于Solanum nigrum的抗黑色素瘤作用的分子实体

Neha Sakharkar^1,2, Ruchika Kaul-Ghanekar², Yingying Song³

¹Bharati Vidyapeeth University, Pune - 411043, Maharashtra, India.

|July 10, 2025

概括

黑色 (Solanum nigrum) 显示出强大的抗黑色素瘤活性,表现优于其他草药. 它的活性化合物迪奥斯基宁和索拉诺素显示出向关键黑色素瘤基因的潜力.

科学领域:

植物化学植物化学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

晚期和转移性黑色素瘤的预后很差.
黑色素瘤患者经常使用补充和替代药物来提高治疗疗效.
黑色 (Solanum nigrum) 对黑色素瘤细胞具有显著的抑制活性.

研究的目的:

为了研究Solanum nigrum的抗黑色素瘤特性.
为了确定Solanum nigrum中具有抗黑色素瘤潜力的活性化合物.
探索这些化合物在黑色素瘤中的分子点.

主要方法:

对Solanum nigrum与其他药用草本 (Hedyotis diffusa,Scutellaria barbata,Lobelia chinensis) 的比较分析.
在Solanum nigrum中的活性成分的识别.
分析与黑色素瘤相关的基因标.

主要成果:

与其他测试的草药相比,Solanum nigrum显示出对黑色素瘤细胞的优越抑制活性.
在Solanum nigrum中发现了两种活性成分 - - 迪奥斯基宁和索拉诺素.
对于这些活性成分,已确定了三种与黑色素瘤相关的基因标 (CYP3A4,GBA2和PTK6).

结论:

黑色 (Solanum nigrum) 具有显著的抗黑色素瘤潜力.
迪奥斯基宁和索拉诺辛是Solanum nigrum中具有治疗前景的关键活性化合物.
已确定的基因标 (CYP3A4,GBA2,PTK6) 代表了Solanum nigrum抗黑色素瘤作用的潜在机制.

关键词:

索兰尼格鲁姆 (Solanum nigrum) 是一个黑色的植物.基因表达的基因表达方式黑色素瘤是一种黑色素瘤.独特的活性成分独特的活性成分.独特的目标,独特的目标.

更多相关视频

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...